Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Inhaled Anesthesia in Pancreatic Cancer Surgery
NCT04992507Phase 2Terminated
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jun 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
A Phase 2 trial of propofol + remifentanil in pancreatic adenocarcinoma (PDAC), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Jun 2023; status: terminated.
02
Drugs
propofol + remifentanil
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04992507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992507.